Wereport a case of massive pulmonaryhemorrhagewhich emergedin the course of polyarteritis nodosa (PN). Pulmonaryhemorrhagewas the major manifestation whichdetermined the mortality of this patient, though severe renal failure concurrently developed. The diagnosis of PNshould be considered in all cases of pulmonary hemorrhage coexisting with renal failure. As pulmonary hemorrhage can be life-threatening, early diagnosis is essential for the prompt start of adequate therapy.
Although polyarteritis nodosa (PN) is a disease that can affect manyorgans of the body, massive pulmonary hemorrhage due to lung involvement is a rare manifestation (1, 2) . The diagnosis of PN is difficult in patients with hemoptysis and renal failure, because in addition to several other disorders such as Goodpasture's syndrome, Wegener's granulomatosis (7) (8) (9) , and systemic lupus erythematosus (10-ll) more frequently cause pulmonary hemorrhage coexistent with rapidly progressing renal failure. Although immunosuppressive therapy is commonly used in all of these diseases, the treatments vary somewhat. As for the treatment of pulmonary hemorrhage in Goodpasture's syndrome, plasma exchange should be performed in addition to the administration of high dose steroid.
Pulmonary hemorrhage has recently been recognized as a significant contributory factor in the mortality of PN (12 The prothrombin time, the partial thromboplastin time and other coagulation tests were normal. The urine had a specific gravity of 1.010, and gave a test for 1 + glucose, 2 + protein; the sediment contained numerous red blood cells, 3 to 4 white blood cells per high-power field, and no casts. An electrocardiogram revealed sinus tachycardia and supraventricular extrasystole. An x-ray film of the chest ( On the fourth hospital day, PO2 abruptly fell with the development of massive hemoptysis. Intubation was performed and mechanical ventilation was started. Fiberoptic bronchoscopy revealed no endobronchial lesion but there was diffuse hemor- rhage from all of the right bronchial divisions. At this time, Goodpasture's syndromewas considered to be the most probable diagnosis, and methylprednisolone pulse therapy combined with plasma exchange was performed. Although plasma exchange (5 1/day) was performed on three consecutive days, no improvement of PO2 was observed, hemoptysis still continued, and infiltration on chest roentgenogram spread to the left lung. On the ninth hospital day, because this clinical course was considered atypical of Goodpasture's syndrome in terms of the poor response to plasma exchange, percutaneous needle renal biopsy was performed for the definite diagnosis.
The biopsy specimen showed marked fibrinoid necrosis of interlobular and arcuate arteries with no granulomatous lesions, and no findings of crescentic glomerulonephritis. Immunofluorescence study showed no anti-GBM antibody deposition. At this time anti-GBM antibody was reported negative. These findings confirmed the diagnosis of polyarteritis nodosa, and subsequently cyclophosphamide (100 mg/day) was added to the treatment regimen on the 16th hospital day. However, the PO2 continued to fall despite further elevation of the inspiratory oxygen concentration (Fig. 2) obvious source of bleeding was found in the tracheobronchial lesions. Light microscopy demonstrated diffuse intra-alveolar hemorrhage and hemosiderin-laden macrophages, and the fibrotic change of interalveolar septurns was also found. There was no apparent signs of alveolar capillaritis, and arterioles and the larger pulmonary vessels were free of inflammation. Granulomas were not seen (Fig. 3).
Kidneys were atrophic, and brown in color.
Sections through kidneys revealed indistinct corticomedullary junction, numerous infarcted areas, and thrombi in almost all larger vessels. Light microscopy disclosed that almost all arteries in the kidney, especially arcuate arteries were affected by the marked necrotizing vasculitis. In glomeruli, only ischemic changes were noted (Figs. 4, 5) . The other involved organs were spleen, pancreas, heart, liver, adrenal glands and gastrointestinal tract.
Skin, muscles, peripheral nerves and brain were not examined in this case.
DISCUSSION
Massive pulmonary hemorrhage is an uncommon manifestation of PN. In Japan, only two cases have been reported (3 , 4) . In patients with hemoptysis and rapidly progressing renal failure, the differential diagnosis is difficult. As lung hemorrhage is rare in PN, the diagnosis of PNis often overlooked in favor of other diseases like Goodpasture's syndromeor Wegener's granulomatosis. However, Haworth et al (12) reported recently that pulmonary hemorrhage occurred in seven of thirty-six patients with microscopic polyarteritis causing serious morbidity. Thus, they emphasized the importance of the early recognition and treatment of pulmonary hemorrhage.
A therapeutic approach to the patients of PN with pulmonary hemorrhage has not been established and may well be different from that employed in Goodpasture's syndrome. Therefore, the definite diagnosis of PNconfirmed by histological examination may be essential. However, the histological findings of pulmonary hemorrhage in PNare often non-specific and vasculitis is usually not observed in the lung. Although Mark and Ramirez proposed diagnostic criteria for pulmonary capillaritis (1 3), it is often difficult to recognize, even for pathologists, and especially for those who are not experts in the pathology of non-neoplastic pulmonary diseases. In fact, in this case no vasculitis was observed in the autopsy of the lung. The influence of O2 toxicity, immunosuppressive therapy, and superimposed infection on the pulmonary lesions of PN maymake the recognition of underlying capillaritis difficult in the autopsy material. Therefore, diagnosis should be made as soon as possible by renal biopsy as well as by renal angiography. As the initial diagnosis in this case was Goodpasture's syndrome, plasma exchange was added to high dose steroid treatment. But cyclophosphamide was started on the 10th hospital day, when the diagnosis of PN was finally established. This delay could be critical because the addition of cyclophosphamide is important if vasculitis is present.
The diagnosis of pulmonary hemorrhage is usually based on the clinical and roentgenographic manifestations, such as hemoptysis, infiltrates on the chest roentgenogram, anemia, dyspnea, and occasionally fever or chest pain, and most patients are too ill to tolerate an invasive study like transbronchial lung biopsy as in our case (14, 15 In contrast, our case showedonly a slight elevation of the circulating immunecomplex level, which might account for the lack of response to the plasma exchange. Further studies are necessary to evaluate the efficacy of plasma exchange for PN. In summary, a case of PNwas described in which the majormanifestations were massivepulmonary hemorrhage and renal failure. This case report suggests that pulmonaryhemorrhagecan be one of the important factors determining the prognosis of the patient with PN.
